Olson Kenneth Fletcher 4
4 · HARVARD BIOSCIENCE INC · Filed Nov 6, 2019
Insider Transaction Report
Form 4
Olson Kenneth Fletcher
Vice President
Transactions
- Award
Common Stock
2019-11-01+16,949→ 16,949 total - Award
Stock option (right to buy)
2019-11-01+37,037→ 37,037 totalExercise: $2.95From: 2020-11-01Exp: 2029-11-01→ Common Stock, par value $0.01 per share (37,037 underlying)
Footnotes (3)
- [F1]Represents a deferred stock award of 16,949 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in equal installments on November 1, 2020, 2021 and 2022, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from November 1, 2019 to the earlier of (i) November 1, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date, or with respect to a change of control, the per share purchase price in the change of control). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
- [F2]Includes the award described in footnote (1) above.
- [F3]The options vest in four equal installments on November 1, 2020, 2021, 2022 and 2023.